Stifel Initiates Coverage On Inari Medical with Hold Rating, Announces Price Target of $50
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Mathew Blackman has initiated coverage on Inari Medical (NASDAQ:NARI) with a Hold rating and set a price target of $50.
September 17, 2024 | 8:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel has initiated coverage on Inari Medical with a Hold rating and a price target of $50, indicating a neutral stance on the stock.
The Hold rating suggests that the analyst does not expect significant movement in the stock price in the short term. The price target of $50 provides a benchmark for investors, indicating that the stock is fairly valued at current levels.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100